These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 11809115

  • 21. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 22. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
    [Abstract] [Full Text] [Related]

  • 23. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, Tang CS, Chan TM.
    Nephrology (Carlton); 2012 May 23; 17(4):352-7. PubMed ID: 22295934
    [Abstract] [Full Text] [Related]

  • 24. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
    Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G.
    Pediatr Nephrol; 2016 Nov 23; 31(11):2095-101. PubMed ID: 27263020
    [Abstract] [Full Text] [Related]

  • 25. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
    Nephrology (Carlton); 2015 Jan 23; 20(1):18-24. PubMed ID: 25312783
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul 23; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil in the treatment of glomerular diseases.
    Grcevska L, Polenakovic M.
    Prilozi; 2007 Jul 23; 28(1):57-68. PubMed ID: 17921918
    [Abstract] [Full Text] [Related]

  • 28. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, Trachtman H, Swinford R.
    Clin J Am Soc Nephrol; 2006 Nov 23; 1(6):1173-8. PubMed ID: 17699344
    [Abstract] [Full Text] [Related]

  • 29. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
    Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical AssociationDepartment of Pediatrics, Nanjing General Hospital of Nanjing Military Command, Nanjing 21002, China. Email:njxzk@126.com..
    Zhonghua Er Ke Za Zhi; 2014 Jul 23; 52(7):483-7. PubMed ID: 25224050
    [Abstract] [Full Text] [Related]

  • 30. [Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types].
    Xia ZK, Liu GL, Gao YF, Fu J, Fu YF, Zhang LF, Fan ZM.
    Zhonghua Er Ke Za Zhi; 2003 Nov 23; 41(11):813-6. PubMed ID: 14728885
    [Abstract] [Full Text] [Related]

  • 31. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
    Pediatr Int; 2015 Nov 23; 57(1):85-91. PubMed ID: 25225083
    [Abstract] [Full Text] [Related]

  • 32. Mycophenolate mofetil in children with multidrug-resistant nephrotic syndrome.
    Bayazit AK, Noyan A, Cengiz N, Anarat A.
    Clin Nephrol; 2004 Jan 23; 61(1):25-9. PubMed ID: 14964454
    [Abstract] [Full Text] [Related]

  • 33. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome.
    Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D.
    Nephrol Dial Transplant; 2002 Nov 23; 17(11):2011-3. PubMed ID: 12401863
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome.
    Liu XW, Li DM, Xu GS, Sun SR.
    Int J Clin Pharmacol Ther; 2010 Aug 23; 48(8):509-13. PubMed ID: 20650041
    [Abstract] [Full Text] [Related]

  • 35. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct 23; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.
    Dussol B, Morange S, Burtey S, Indreies M, Cassuto E, Mourad G, Villar E, Pouteil-Noble C, Karaaslan H, Sichez H, Lasseur C, Delmas Y, Nogier MB, Fathallah M, Loundou A, Mayor V, Berland Y.
    Am J Kidney Dis; 2008 Oct 23; 52(4):699-705. PubMed ID: 18585835
    [Abstract] [Full Text] [Related]

  • 37. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV.
    Clin Transplant; 1996 Feb 23; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [Abstract] [Full Text] [Related]

  • 38. Retrospective study of mycophenolate mofetil treatment in IgA nephropathy with proliferative pathological phenotype.
    Liang Y, Zhang J, Liu D, Quan S, Xing G, Liu Z.
    Chin Med J (Engl); 2014 Feb 23; 127(1):102-8. PubMed ID: 24384432
    [Abstract] [Full Text] [Related]

  • 39. Mycophenolate mofetil treatment for primary glomerular diseases.
    Choi MJ, Eustace JA, Gimenez LF, Atta MG, Scheel PJ, Sothinathan R, Briggs WA.
    Kidney Int; 2002 Mar 23; 61(3):1098-114. PubMed ID: 11849465
    [Abstract] [Full Text] [Related]

  • 40. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.
    Gellermann J, Querfeld U.
    Pediatr Nephrol; 2004 Jan 23; 19(1):101-4. PubMed ID: 14753204
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.